Pharmacy benefit manager startup Capital Rx gets $106M in funding

Tech-powered pharmacy benefit startup Capital Rx has closed on $106 million in series C funding as it aims to expand its efforts to better coordinate prescribing.

Advertisement

The company’s platform includes such features as claims adjudication, prior authorization and billing and reimbursement, and serves entities including health plans, health systems and prescribers.

“Our country cannot continue to operate on disparate and antiquated technology, and our goal is to provide our nation the infrastructure it needs for the healthcare system we deserve,” Capital Rx CEO AJ Loiacono said in a June 13 company news release.

The startup said its membership has doubled in the last year and that it expects to add 1 million patients for the 2023 plan year.

The investment round was led by B Capital and also featured General Catalyst. It increases Capital Rx’s overall funding to $175 million.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

What clinicians need from AI after the pilot: Lessons from Adventist Health and Rady Children’s

Friday, July 24
12:00 PM - 1:00 PM CDT

Presenters: Dr. Dieter Sumerauer, Rady Children’s HealthDr. Salman Naqvi, AdventistDr. Reid Conant, Abridge

Advertisement

Next Up in Digital Health

Advertisement

Comments are closed.